Stories
Sort by: Featured Most recent
1 result total, viewing 1 - 1
A graphic depiction of how aberrant innate immune cells in the blood pass through the blood brain barrier and disrupt and damage the synaptic process in the brain.
Nipping Alzheimer’s disease in the blood
KINGSTON – MindImmune, a drug discovery firm, working in collaboration with the George & Anne Ryan Institute for Neuroscience at URI, recently completed a $12.4 million Series A round of … more
|
Currently viewing stories posted within the past 90 days.
For all older stories, please use our advanced search.

© convergenceri.com | subscribe | contact us | report problem | About | Advertise

powered by creative circle media solutions

Join the conversation

Want to get ConvergenceRI
in your inbox every Monday?

Type of subscription (choose one):
Business
Individual

We will contact you with subscription details.

Thank you for subscribing!

We will contact you shortly with subscription details.